ARCHIVES

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987

New “JNC” Popular Replacement For Old Journals

May 20, 1988

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988